SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,926.83 |
| Enterprise Value ($M) | 2,361.50 |
| Book Value ($M) | 577.18 |
| Book Value / Share | 3.47 |
| Price / Book | 5.07 |
| NCAV ($M) | 388.60 |
| NCAV / Share | 2.34 |
| Price / NCAV | 7.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.21 |
| Return on Assets (ROA) | 0.20 |
| Return on Equity (ROE) | 0.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.11 |
| Current Ratio | 2.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 788.28 |
| Assets | 976.87 |
| Liabilities | 399.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 8.30 | 21.81 | |
| 13G/A | Vanguard Group Inc | 8.16 | 0.88 | |
| 13G/A | Fmr Llc | 3.21 | -43.59 | |
| 13G/A | BlackRock Inc. | 6.90 | 11.21 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 190,790 | 744,879 | 25.61 | |
| 156,401 | 704,199 | 22.21 | |
| 121,420 | 693,306 | 17.51 | |
| 150,874 | 1,152,735 | 13.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ABUS – Arbutus Biopharma Corporation | ACLX – Arcellx, Inc. |
| ACRS – Aclaris Therapeutics, Inc. |